A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01035333|
Recruitment Status : Completed
First Posted : December 18, 2009
Results First Posted : April 4, 2014
Last Update Posted : April 4, 2014
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Drug: Orlistat||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||19 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.|
|Study Start Date :||November 2009|
|Actual Primary Completion Date :||April 2011|
|Actual Study Completion Date :||April 2011|
Experimental: orlistat 60mg
Patients assigned to treatment group for up to 6 months of therapy.
60mg capsule three times a day for up to 6 months
Other Name: Alli
- Weight Loss [ Time Frame: 6 months ]Weight loss acheived during time on study up to 6 months.
- Patient Satisfaction [ Time Frame: 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01035333
|United States, New York|
|Albany College of Pharmacy and Health Sciences|
|Albany, New York, United States, 12208|
|Principal Investigator:||Margaret Malone, PhD||Albany College of Pharmacy and Health Sciences|